Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARES: 40-Week Safety Continuation of Asenapine vs Olanzapine in Bipolar Mania
NCT00159783Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in bipolar disorder (BD), sponsored by Organon & Co.. Started Jul 2005; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00159783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159783.